Oxford Immunotec Ltd – Product Pipeline Analysis, 2016 Update

GlobalDataが発行した調査報告書(GDME6331PD)
◆英語タイトル:Oxford Immunotec Ltd - Product Pipeline Analysis, 2016 Update
◆商品コード:GDME6331PD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年12月28日
◆ページ数:39
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD1,500 ⇒換算¥163,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD2,250 ⇒換算¥245,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Oxford Immunotec Ltd (Oxford Immunotec) is a medical device company that develops and commercializes proprietary tests. The company provides international T cell measurement products including T-Cell Xtend and T-SPOT. Its T-SPOT.TB test diagnoses both latent TB infection and active disease by measuring T cells that have been activated by Mycobacterium tuberculosis antigens. Oxford Immunotec’s T-SPOT.CMV is a factor in controlling viral latency and vulnerability to CMV disease. The company’s T-Cell Xtend reagent is an antibody complex added to blood samples in the laboratory before running the T-SPOT.TB assay. Its T-SPOT solution offers diagnosing disease by providing a method of measuring immune response to an infection. The company markets its products in the US, several European countries and Japan. Oxford Immunotec is headquartered in Abingdon, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Oxford Immunotec Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Oxford Immunotec Ltd Company Overview 6
Oxford Immunotec Ltd Company Snapshot 6
Oxford Immunotec Ltd Pipeline Products and Clinical Trials Overview 7
Oxford Immunotec Ltd – Pipeline Analysis Overview 9
Key Facts 9
Oxford Immunotec Ltd – Major Products and Services 10
Oxford Immunotec Ltd Pipeline Products by Development Stage 11
Oxford Immunotec Ltd Pipeline Products Overview 15
B Cell ELISPOT Assay 15
B Cell ELISPOT Assay Product Overview 15
GoutiFind Test 16
GoutiFind Test Product Overview 16
I-O Monitoring Test 17
I-O Monitoring Test Product Overview 17
Metabovis Assay – Homocysteine 18
Metabovis Assay – Homocysteine Product Overview 18
Nucleic Acid Amplification Test – Babesia 19
Nucleic Acid Amplification Test – Babesia Product Overview 19
Serology Test – Babesia 20
Serology Test – Babesia Product Overview 20
SpiroFind 21
SpiroFind Product Overview 21
Stratokine 22
Stratokine Product Overview 22
T-SPOT.CMV 23
T-SPOT.CMV Product Overview 23
T-SPOT.CMV Clinical Trial 24
T-SPOT.ICA 25
T-SPOT.ICA Product Overview 25
T-SPOT.PRT 26
T-SPOT.PRT Product Overview 26
T-SPOT.PRT Clinical Trial 27
UREA And T-SPOT Based Diagnostic Assay – Immunological Disease 28
UREA And T-SPOT Based Diagnostic Assay – Immunological Disease Product Overview 28
UREA And T-SPOT Based Diagnostic Assay – Infectious Disease 29
UREA And T-SPOT Based Diagnostic Assay – Infectious Disease Product Overview 29
Oxford Immunotec Ltd – Key Competitors 30
Oxford Immunotec Ltd – Key Employees 31
Oxford Immunotec Ltd – Locations And Subsidiaries 32
Head Office 32
Other Locations & Subsidiaries 32
Recent Developments 33
Oxford Immunotec Ltd, Recent Developments 33
Dec 08, 2016: Oxford Immunotec Announces New England Journal of Medicine Publication on Clinical Trial Results of Serological and Nucleic Acid Tests for Babesia in Blood Screening 33
Dec 22, 2015: Oxford Immunotec Announces CE Mark for the T-SPOT.PRT Test 33
Dec 03, 2015: Oxford Immunotec Announces Availability of the T-SPOT.PRT Test in the United States 34
Nov 30, 2015: Oxford Immunotec Selected to Test New Entrants for TB in UK National Tender 34
Jun 11, 2015: Oxford Immunotec Announces First Patient Enrolled in REACT Trial for T-SPOT.CMV 34
Apr 27, 2015: Oxford Immunotec Announces CE Mark Approval for T-SPOT.CMV Test 35
Mar 31, 2015: Oxford Immunotec Announces Availability of the T-SPOT.CMV Test in the United States 35
Feb 05, 2015: Oxford Immunotec Announces First Patients Enrolled in PROTECT Trial for T-SPOT.PRT 36
Feb 05, 2015: Oxford Immunotec Announces First Patients Enrolled in PROTECT Trial for T-SPOT.CMV 36
Jan 06, 2015: Oxford Immunotec Announces Completion of Re-Registration in China for T-SPOT.TB Test 36
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Oxford Immunotec Ltd Pipeline Products and Clinical Trials Overview 7
Oxford Immunotec Ltd Pipeline Products by Equipment Type 7
Oxford Immunotec Ltd Pipeline Products by Indication 8
Oxford Immunotec Ltd Clinical Trials by Trial Status 8
Oxford Immunotec Ltd, Key Facts 9
Oxford Immunotec Ltd, Major Products and Services 10
Oxford Immunotec Ltd Number of Pipeline Products by Development Stage 11
Oxford Immunotec Ltd Pipeline Products Summary by Development Stage 12
Oxford Immunotec Ltd Clinical Trials by Trial Status 13
Oxford Immunotec Ltd Clinical Trials Summary 14
B Cell ELISPOT Assay - Product Status 15
B Cell ELISPOT Assay - Product Description 15
GoutiFind Test - Product Status 16
GoutiFind Test - Product Description 16
I-O Monitoring Test - Product Status 17
I-O Monitoring Test - Product Description 17
Metabovis Assay - Homocysteine - Product Status 18
Metabovis Assay - Homocysteine - Product Description 18
Nucleic Acid Amplification Test - Babesia - Product Status 19
Nucleic Acid Amplification Test - Babesia - Product Description 19
Serology Test - Babesia - Product Status 20
Serology Test - Babesia - Product Description 20
SpiroFind - Product Status 21
SpiroFind - Product Description 21
Stratokine - Product Status 22
Stratokine - Product Description 22
T-SPOT.CMV - Product Status 23
T-SPOT.CMV - Product Description 23
T-SPOT.CMV - A Prospective Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation Events - Assessed by a CMV-Specific T-SPOT Assay: The REACT Study 24
T-SPOT.CMV - Clinical Value of Oxford Immunotec’s T-SPOT.CMV and T-SPOT.PRT for the Management of Immune-regulated Conditions 24
T-SPOT.ICA - Product Status 25
T-SPOT.ICA - Product Description 25
T-SPOT.PRT - Product Status 26
T-SPOT.PRT - Product Description 26
T-SPOT.PRT - Clinical Value of Oxford Immunotec’s T-SPOT.CMV and T-SPOT.PRT for the Management of Immune-regulated Conditions 27
UREA And T-SPOT Based Diagnostic Assay - Immunological Disease - Product Status 28
UREA And T-SPOT Based Diagnostic Assay - Immunological Disease - Product Description 28
UREA And T-SPOT Based Diagnostic Assay - Infectious Disease - Product Status 29
UREA And T-SPOT Based Diagnostic Assay - Infectious Disease - Product Description 29
Oxford Immunotec Ltd, Key Employees 31
Oxford Immunotec Ltd, Subsidiaries 32

List of Figures
Oxford Immunotec Ltd Pipeline Products by Equipment Type 8
Oxford Immunotec Ltd Pipeline Products by Development Stage 11

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Oxford Immunotec Ltd – Product Pipeline Analysis, 2016 Update(Oxford Immunotec Ltd - Product Pipeline Analysis, 2016 Update)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆